Ubiquitin-specific proteases as cancer drug targets

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Drug Discovery

Background:

• Ubiquitin-specific proteases (USPs) are enzymes that remove ubiquitin from proteins.
• This process is crucial for protein stability, localization, and activation.
• Dysregulation of USPs, including DNA alteration and overexpression, is observed in various cancers, implicating them in cancer-associated pathways.

Purpose of the Study:

• To review ubiquitin-specific proteases (USPs) as potential cancer drug targets.
• To evaluate the validation and druggability of USPs in cancer therapy.
• To highlight the pharmacological potential of targeting USP proteolytic activity.

Main Methods:

• Literature review of USP functions in cancer.
• Analysis of structural biology data related to USPs.
• Assessment of USP involvement in cancer-associated pathways.
• Evaluation of USP druggability for therapeutic intervention.

Main Results:

• USPs play significant roles in cancer development and progression.
• Their enzymatic activity and involvement in protein homeostasis present therapeutic opportunities.
• Structural data supports the potential for designing inhibitors against USPs.
• USPs are validated as promising targets for cancer drug discovery.

Conclusions:

• Ubiquitin-specific proteases represent a validated class of drug targets for cancer therapy.
• The druggability of USPs, supported by structural and functional data, offers significant potential for pharmacological intervention.
• Targeting USPs could lead to novel therapeutic strategies for various cancer types.